ANGPTL3 and homozygous familial hypercholesterolemia: We also observed a small but consistent increase in LDL apoB production rate and a more substantial increase in LDL apoB FCR, suggesting that ANGPTL3 inhibition may also directly affect LDL apoB metabolism in patients with hoFH.